Your browser doesn't support javascript.
loading
Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers.
Zhu, Hao-Jie; Patrick, Kennerly S; Straughn, Arthur B; Reeves, Owen T; Bernstein, Hilary; Shi, Jian; Johnson, Heather J; Knight, Joshua M; Smith, Aaron T; Malcolm, Robert J; Markowitz, John S.
Affiliation
  • Zhu HJ; From the *Department of Clinical Pharmacy, University of Michigan, Ann Arbor, MI; †Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC; ‡Department of Pharmaceutical Sciences, University of Tennessee Health Sciences Center, Memphis, TN; §Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC; and ∥Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, FL.
J Clin Psychopharmacol ; 37(4): 419-428, 2017 Aug.
Article in En | MEDLINE | ID: mdl-28590363
ABSTRACT
BACKGROUND/

PURPOSE:

Ethanol coadministered with immediate-release dl-methylphenidate (dl-MPH) or dexmethylphenidate (d-MPH) significantly increases the geomean maximum plasma concentration (Cmax) of d-MPH 22% and 15%, respectively, and elevates overall drug exposure and psychostimulant effects. We asked the question Are these ethanol-MPH interactions based more fundamentally on (1) inhibition of postabsorption d-MPH metabolism or (2) acceleration of MPH formulation gastric dissolution by ethanol in the stomach? This was investigated using the pulsatile, distinctly biphasic, spheroidal oral drug absorption systems of dl-MPH and d-MPH.

METHODS:

In a randomized, 4-way crossover study, 14 healthy subjects received pulsatile dl-MPH (40 mg) or d-MPH (20 mg), with or without ethanol (0.6 g/kg), dosed 4 hours later. These 4 hours allowed the delayed-release second MPH pulse to reach a more distal region of the gut to preclude gastric biopharmaceutical influences. Plasma was analyzed using a highly sensitive chiral method. Subjective/physiological effects were recorded. FINDINGS/

RESULTS:

Ethanol increased the second pulse of d-MPH Cmax for dl-MPH by 35% (P < 0.01) and the partial area under the plasma concentration curve from 4 to 8 hours by 25% (P < 0.05). The respective values for enantiopure d-MPH were 27% (P = 0.001) and 20% (P < 0.01). The carboxylesterase 1-mediated transesterification metabolite ethylphenidate served as a biomarker for coexposure. Ethanol significantly potentiated stimulant responses to either formulation. IMPLICATIONS/

CONCLUSIONS:

These findings support drug dispositional interactions between ethanol and MPH as dominant over potential biopharmaceutical considerations. Understanding the pharmacology underlying the frequent coabuse of MPH-ethanol provides rational guidance in the selection of first-line pharmacotherapy for comorbid attention-deficit/hyperactivity disorder-alcohol use disorder.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ethanol / Dexmethylphenidate Hydrochloride / Methylphenidate Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Psychopharmacol Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ethanol / Dexmethylphenidate Hydrochloride / Methylphenidate Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Psychopharmacol Year: 2017 Document type: Article